VOYA Investment Management’s Aquestive Therapeutics AQST Stock Holding History

VOYA Investment Management’s Portfolio AQST Stock Details AQST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$87.9K	Buy	21,139 +3,667	+21%	+$15.4K	﹤0.01%	2368
2026 Q1	$72.5K	Hold	17,472	–	–	﹤0.01%	2233
2025 Q4	$113K	Buy	17,472 +928	+6%	+$5.78K	﹤0.01%	2244
2025 Q3	$92.5K	Sell	16,544 -8,083	-33%	-$34.9K	﹤0.01%	2314
2025 Q2	$81.5K	Buy	24,627 +4,411	+22%	+$12.7K	﹤0.01%	2530
2025 Q1	$58.6K	Sell	20,216 -3,485	-15%	-$10.6K	﹤0.01%	2526
2024 Q4	$84.4K	Sell	23,701 -1,214	-5%	-$5.6K	﹤0.01%	2612
2024 Q3	$124K	Sell	24,915 -926	-4%	-$3.6K	﹤0.01%	2611
2024 Q2	$67.2K	Buy	+25,841	New	+$86.3K	﹤0.01%	2753
2021 Q2	–	Sell	-10,040	Closed	-$52K	–	2808
2021 Q1	$52K	Buy	+10,040	New	+$53.4K	﹤0.01%	2742

Other funds holding AQST

BCM

Bratton Capital Management Fort Worth, Texas $40.8M AUM 25.68% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

SCM

Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return

VOYA Investment Management's AQST Position: Q2 2026 in Review

VOYA Investment Management increased its Aquestive Therapeutics (AQST) stake by 21% in Q2 2026, buying an estimated $15.4K and bringing the position to 21,139 shares worth $87.9K. The position accounts for ﹤0.01% of the portfolio, ranked #2368.

VOYA Investment Management first reported a position in AQST in Q1 2021 and has held it in 10 quarters since. The position peaked at $124K in Q3 2024. 184 funds tracked by Wall St. Rank hold AQST as of Q2 2026.

VOYA Investment Management held 21,139 shares of Aquestive Therapeutics worth $87.9K as of Q2 2026.
VOYA Investment Management bought 3,667 Aquestive Therapeutics shares in Q2 2026, an estimated $15.4K.
Aquestive Therapeutics made up ﹤0.01% of VOYA Investment Management's portfolio in Q2 2026, its #2368 holding.
VOYA Investment Management first reported a position in Aquestive Therapeutics in Q1 2021 and has held it in 10 quarters since.
VOYA Investment Management's Aquestive Therapeutics position peaked at $124K in Q3 2024.
184 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q2 2026.

Based on VOYA Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.